|Phase of Study:||Phase I|
|Treatment Location:||Both at MDACC & outside MDACC at one or more Collaborating Sites or Institutions|
|Estimated Length of Stay in Houston:||N/A|
|Supported By:||Pharmacyclics, Inc.|
|Return Visit:||At the beginning of each cycle, then every 2-3 months until the participant has |
disease progression for a maximum of 6 months.
|Home Care:||The study drug will be taken at home.|